Summary
Background
Impaired glucose regulation (IGR) and diabetes mellitus (DM) are amongst the main risk factors for developing coronary heart disease (CHD). The aim of this study was to investigate previously unknown glucose metabolism disorder in patients scheduled for an elective coronary angiography.
Methods
A total of 141 patients scheduled for coronary angiography without signs of acute myocardial ischemia or previous history of a glucose metabolism disorder were prospectively included in the study. An oral glucose tolerance test (OGTT) was performed in each patient.
Results
IGR was diagnosed in 40.4% (95% confidence interval 32.3–49.0) and undetected DM in 22.7% (16.1–30.5) of patients undergoing an elective coronary angiography. Depending on the severity of CHD, the percentage of IGR and DM increased up to 45.3% (34.6–56.5) and 26.7% (17.8–37.4) in the subgroup with the need of percutaneous angioplasty, while the corresponding proportions in the group without CHD were 30.3% (15.6–48.7) and 12.1% (3.4–28.2). The percentage of undiagnosed DM increased with the number of epicardial vessels involved. Using the recommended fasting plasma glucose value of ≥ 126 mg/dl for the diagnosis of DM, we would have missed 71.9% of the patients with undiagnosed DM.
If all patients with a fasting plasma glucose of ≥ 90 mg/dl had been subjected to OGTT, 93.8% of DM would have been identified.
Conclusions
Prevalences of DM and IGR are higher than expected in patients with CHD. An OGTT should be considered for all patients with a fasting plasma glucose ≥ 90 mg/dl undergoing a coronary angiography.
Similar content being viewed by others
References
Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229–234
Hu FB, Stampfer MJ, Haffner SM, Solomon CG, Willett WC, Manson JE (2002) Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes. Diabetes Care 25:1129–1134
The DECODE Study Group the European Diabetes Epidemiology Group (1999) Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. Lancet 354:617–621
Rathmann W, Haastert B, Icks A, Lowel H, Meisinger C, Holle R et al (2003) High prevalence of undiagnosed diabetes mellitus in Southern Germany: target populations for efficient screening. The KORA survey 2000. Diabetologia 46:182–189
Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne– Parikka P et al (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343–1350
Knowler WC, Barrett–Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA et al (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393–403
Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M (2002) Acarbose for prevention of type 2 diabetes mellitus: the STOPNIDDM randomised trial. Lancet 359:2072–2077
Intensive blood–glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) (1998) UK Prospective Diabetes Study (UKPDS) Group. Lancet 352:837–853
Malmberg K (1997) Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. BMJ 314:1512–1515
Effect of intensive blood–glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) (1998) UK Prospective Diabetes Study (UKPDS) Group. Lancet 352:854–865
Hanefeld M, Cagatay M, Petrowitsch T, Neuser D, Petzinna D, Rupp M (2004) Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta–analysis of seven long–term studies. Eur Heart J 25:10– 16
Van den BG, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M et al (2001) Intensive insulin therapy in the critically ill patients. N Engl J Med 345:1359–1367
Norhammar A, Tenerz A, Nilsson G, Hamsten A, Efendic S, Ryden L et al (2002) Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 359:2140–2144
Rathmann W, Icks A, Haastert B, Giani G, Lowel H, Mielck A (2002) Undiagnosed diabetes mellitus among patients with prior myocardial infarction. Z Kardiol 91:620–625
Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539–553
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta–cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419
Kowalska I, Prokop J, Bachorzewska– Gajewska H, Telejko B, Kinalskal I, Kochman W et al (2001) Disturbances of glucose metabolism in men referred for coronary arteriography. Postload glycemia as predictor for coronary atherosclerosis. Diabetes Care 24:897–901
Taubert G, Winkelmann BR, Schleiffer T, Marz W, Winkler R, Gok R et al (2003) Prevalence, predictors, and consequences of unrecognized diabetes mellitus in 3266 patients scheduled for coronary angiography. Am Heart J 145:285–291
Bartnik M, Ryden L, Ferrari R, Malmberg K, Pyorala K, Simoons M et al (2004) The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart. Eur Heart J 25:1880–1890
Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047–1053
Mannebach H, Hamm C, Horstkotte D (2002) 18th report of the statistics of heart catheter laboratories in Germany. Results of a combined survey by the Committee of Clinical Cardiology and the Interventional Cardiology and Angiology Working Group (for ESC) of the German Society of Cardiology–Heart– and Cardiovascular Research 2001. Z Kardiol 91:727– 729
The DECODE Study Group the European Diabetes Epidemiology Group (2001) Glucose tolerance and cardiovascular mortality: comparison of fasting and 2–hour diagnostic criteria. Arch Intern Med 161:397–405
The DECODE Study Group on behalf of the European Diabetes Epidemiology Group (2003) Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases? Diabetes Care 26:688–696
de Vegt F, Dekker JM, Ruhe HG, Stehouwer CD, Nijpels G, Bouter LM et al (1999) Hyperglycaemia is associated with all–cause and cardiovascular mortality in the Hoorn population: the Hoorn Study. Diabetologia 42:926–931
Sasso FC, Carbonara O, Nasti R, Campana B, Marfella R, Torella M et al (2004) Glucose metabolism and coronary heart disease in patients with normal glucose tolerance. JAMA 291:1857–1863
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183–1197
Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R et al (2003) Follow–up report on the diagnosis of diabetes mellitus. Diabetes Care 26:3160–3167
Miettinen H, Lehto S, Salomaa V, Mahonen M, Niemela M, Haffner SM et al (1998) Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group. Diabetes Care 21:69–75
Malmberg K, Yusuf S, Gerstein HC, Brown J, Zhao F, Hunt D et al (2000) Impact of diabetes on long–term prognosis in patients with unstable angina and non–Q–wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry. Circulation 102:1014–1019
Van Belle E, Bauters C, Hubert E, Bodart JC, Abolmaali K, Meurice T et al (1997) Restenosis rates in diabetic patients: a comparison of coronary stenting and balloon angioplasty in native coronary vessels. Circulation 96:1454–1460
Carson JL, Scholz PM, Chen AY, Peterson ED, Gold J, Schneider SH (2002) Diabetes mellitus increases short–term mortality and morbidity in patients undergoing coronary artery bypass graft surgery. J Am Coll Cardiol 40:418–423
Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease (1996) The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. N Engl J Med 335:217–225
Detre KM, Lombardero MS, Brooks MM, Hardison RM, Holubkov R, Sopko G et al (2000) The effect of previous coronary–artery bypass surgery on the prognosis of patients with diabetes who have acute myocardial infarction. Bypass Angioplasty Revascularization Investigation Investigators. N Engl J Med 342:989–997
Kleiman NS, Lincoff AM, Kereiakes DJ, Miller DP, Aguirre FV, Anderson KM et al (1998) Diabetes mellitus, glycoprotein IIb/IIIa blockade, and heparin: evidence for a complex interaction in a multicenter trial. EPILOG Investigators. Circulation 97:1912–1920
Holmes DR Jr, Leon MB, Moses JW, Popma JJ, Cutlip D, Fitzgerald PJ et al (2004) Analysis of 1–year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus–eluting stent versus a standard stent in patients at high risk for coronary restenosis. Circulation 109:634–640
Stone GW, Ellis SG, Cox DA, Hermiller J, O’Shaughnessy C, Mann JT et al (2004) One–year clinical results with the slow–release, polymer–based, paclitaxel– eluting TAXUS stent: the TAXUS–IV trial. Circulation 109:1942–1947
Malmberg K, Norhammar A, Wedel H, Ryden L (1999) Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long–term results from the Diabetes and Insulin–Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation 99:2626–2632
Schnell O, Schafer O, Kleybrink S, Doering W, Standl E, Otter W (2004) Intensification of therapeutic approaches reduces mortality in diabetic patients with acute myocardial infarction: the Munich registry. Diabetes Care 27:455–460
Saydah SH, Fradkin J, Cowie CC (2004) Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA 291:335–342
Norhammar A, Malmberg K, Ryden L, Tornvall P, Stenestrand U, Wallentin L (2003) Under utilisation of evidence– based treatment partially explains for the unfavourable prognosis in diabetic patients with acute myocardial infarction. Eur Heart J 24:838–844
Manson JE, Greenland P, LaCroix AZ, Stefanick ML, Mouton CP, Oberman A et al (2002) Walking compared with vigorous exercise for the prevention of cardiovascular events in women. N Engl J Med 347:716–725
Stevens J, Cai J, Evenson KR, Thomas R (2002) Fitness and fatness as predictors of mortality from all causes and from cardiovascular disease in men and women in the lipid research clinics study. Am J Epidemiol 156:832–841
Wessel TR, Arant CB, Olson MB, Johnson BD, Reis SE, Sharaf BL et al (2004) Relationship of physical fitness vs body mass index with coronary artery disease and cardiovascular events in women. JAMA 292:1179– 1187
de Lorgeril M, Salen P, Martin JL, Monjaud I, Delaye J, Mamelle N (1999) Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation 99:779–785
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lankisch, M., Füth, R., Schotes, D. et al. High prevalence of undiagnosed impaired glucose regulation and diabetes mellitus in patients scheduled for an elective coronary angiography. Clin Res Cardiol 95, 80–87 (2006). https://doi.org/10.1007/s00392-006-0328-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-006-0328-4